The product was earlier approved by the US Food and Drug Administration based on a New Drug Application (NDA) regulatory pathway. New Delhi,Nov.29 : Drug firm Cipla on Tuesday said it has launched Leuprolide Acetate Injection Depot 22.5 mg, used in the treatment of prostate cancer. The product was earlier approved by the US Food […]Continue Reading
